Wanpeng Li, Tian Wang, Haoyuan Xu, Quan Liu, Hao Ding, Dehui Wang. "Tislelizumab as adjuvant therapy following endoscopic surgery for resectable recurrent nasopharyngeal carcinoma: A phase 2 randomized clinical trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e18078